Author details

Full Name

Barry S Rosenstein

Affiliation

ORCID

Career Start Year

1978

Papers

172

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37908014	Reply to: Comments on "(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer".	Int J Cancer	2024
37292833	Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry.	medRxiv	2023
36442608	Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study.	Radiother Oncol	2023
37945903	Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.	Nat Genet	2023
37713940	Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy.	Breast	2023
37862240	Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types.	JNCI Cancer Spectr	2023
37311464	Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.	Am J Hum Genet	2023
37437607	Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer.	Radiother Oncol	2023
37244355	Predicting the germline dependence of hematuria risk in prostate cancer radiotherapy patients.		2023
35123886	Factors associated with late local failure and its influence on survival in men undergoing prostate brachytherapy.	Brachytherapy	2022
35840111	No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity.	Int J Radiat Oncol Biol Phys	2022
35647396	Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort.	Adv Radiat Oncol	2022
35581667	Ocular complications with the use of radium-223: a case series.	Radiat Oncol	2022
36130474	Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort.	EBioMedicine	2022
36195214	The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study.	Radiother Oncol	2022
35334417	Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study).	Lung Cancer	2022
35152271	Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score.	Prostate Cancer Prostatic Dis	2022
33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Nat Genet	2021
33545302	ATM Variants in Breast Cancer: Implications for Breast Radiation Therapy Treatment Recommendations.	International Journal of Radiation Oncology Biology Physics	2021
33473200	Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Nat Genet	2021
33623038	Polygenic hazard score is associated with prostate cancer in multi-ethnic populations.	Nat Commun	2021
34247131	A data science approach for early-stage prediction of Patient's susceptibility to acute side effects of advanced radiotherapy.	Comput Biol Med	2021
33420416	Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer.	Prostate Cancer Prostatic Dis	2021
31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy.	J Natl Cancer Inst	2020
32418335	Genomics models in radiotherapy: From mechanistic to machine learning.		2020
31634634	Response to Letter to the Editor: Regarding "Teaching Radiation and Cancer Biology to Radiation Oncology Residents: A 40-Year Perspective".	Practical Radiation Oncology	2020
31784674	Use of genomics to balance cure and complications.	Nature Reviews Clinical Oncology	2020
32763013	I-125 or Pd-103 for brachytherapy boost in men with high-risk prostate cancer: A comparison of survival and morbidity outcomes.	Brachytherapy	2020
33083651	Survey of Radiation Oncologists to Assess Interest and Potential Use of a Genetic Test Predicting Susceptibility for the Development of Toxicities After Prostate Cancer Radiation Therapy.	Adv Radiat Oncol	2020
33158149	The <i>CHEK2</i> Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor.	Cancers (Basel)	2020
31548585	Publisher Correction: Shared heritability and functional enrichment across six solid cancers.	Nat Commun	2019
31437606	Teaching Radiation and Cancer Biology to Radiation Oncology Residents: AÂ 40-Year Perspective.	Practical Radiation Oncology	2019
30683880	Shared heritability and functional enrichment across six solid cancers.	Nat Commun	2019
31381960	The Implications of Genetic Testing on Radiation Therapy Decisions: A Guide for Radiation Oncologists.	Int J Radiat Oncol Biol Phys	2019
29502932	Machine Learning on a Genome-wide Association Study to Predict Late Genitourinary Toxicity After Prostate Radiation Therapy.	International Journal of Radiation Oncology Biology Physics	2018
29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Nat Genet	2018
29977864	Machine Learning and Radiogenomics: Lessons Learned and Future Directions.	Frontiers in Oncology	2018
30505881	Radiogenomic Predictors of Adverse Effects following Charged Particle Therapy.	Int J Part Ther	2018
30229946	Performance/outcomes data and physician process challenges for practical big data efforts in radiation oncology.	Med Phys	2018
30226926	Genomics, bio specimens, and other biological data: Current status and future directions.	Med Phys	2018
28233873	Computational methods using genome-wide association studies to predict radiotherapy complications and to identify correlative molecular processes.	Sci Rep	2017
28865512	Radiogenomics: Identification of Genomic Predictors for Radiation Toxicity.	Seminars in Radiation Oncology	2017
28497027	Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era.	Front Oncol	2017
28657906	Radiogenomics and radiotherapy response modeling.	Phys Med Biol	2017
27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	EBioMedicine	2016
27302503	Overview of the American Society for Radiation Oncology-National Institutes of Health-American Association of Physicists in Medicine Workshop 2015: Exploring Opportunities for Radiation Oncology in the Era of Big Data.	Int J Radiat Oncol Biol Phys	2016
26797542	How Will Big Data Improve Clinical and Basic Research in Radiation Therapy?	International Journal of Radiation Oncology Biology Physics	2016
27131077	Prospective Randomized Trial of Prone Accelerated Intensity Modulated Breast Radiation Therapy With a Daily Versus Weekly Boost to the Tumor Bed.	Int J Radiat Oncol Biol Phys	2016
26944314	Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity?	Cancer Lett	2016
27443449	Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.	Radiother Oncol	2016